Barnet Caryn S, Liu Xiaoxia, Body Simon C, Collard Charles D, Shernan Stanton K, Muehlschlegel Jochen D, Jarolim Petr, Fox Amanda A
Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Anesthesiology, Fairfax Anesthesia Associates of American Anesthesiology and Virginia Commonwealth University Medical School INOVA campus, Falls Church, Virginia.
Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
J Cardiothorac Vasc Anesth. 2015 Apr;29(2):374-81. doi: 10.1053/j.jvca.2014.11.001. Epub 2014 Nov 11.
Corin is a natriuretic peptide-converting enzyme that cleaves precursor pro-B-type natriuretic peptide to active B-type natriuretic peptide (BNP) (diuretic, natriuretic, and vasodilatory properties). Increased plasma BNP is a known diagnostic and prognostic heart failure (HF) biomarker in ambulatory and surgical patients. Recent studies indicate that plasma corin is decreased significantly in chronic HF patients, yet perioperative plasma corin concentrations have not been assessed in cardiac surgical patients. The objectives of this study were to determine the effect of coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB) on plasma corin concentrations and to assess the association between change in perioperative plasma corin concentration and long-term postoperative HF hospitalization or death. It was hypothesized that plasma corin concentrations decrease significantly from preoperative baseline during postoperative days 1 to 4 and that hospitalization or death from HF during the 5 years after surgery is associated with higher relative difference (preoperative baseline to postoperative nadir) in plasma corin concentrations.
Prospective observational pilot study.
Two institutions: Brigham and Women's Hospital, Boston, Massachusetts and the Texas Heart Institute, St. Luke's Hospital, Houston, Texas.
99 patients of European ancestry who underwent isolated primary CABG surgery with CPB.
Nonemergency isolated primary CABG surgery with CPB.
Plasma corin concentration was assessed preoperatively and at 4 postoperative time points (postoperative days 1-4). HF hospitalization or HF death events during the 5 years after surgery were identified by review of hospital and death records. Postoperative plasma corin concentrations were significantly lower than preoperative baseline concentrations (p<0.0001). Perioperative corin concentrations were significantly higher in males than in females (p<0.0001). Fifteen patients experienced long-term postoperative HF events. Patients who experienced HF hospitalization or HF death during study follow-up had significantly higher relative difference in plasma corin concentration (preoperative baseline to postoperative nadir) than patients who did not experience HF events during study follow-up (p=0.03).
Plasma corin concentrations decrease significantly from preoperative concentrations after CABG surgery. HF hospitalization or HF death during the 5 years after CABG surgery with CPB is associated with larger relative decrease in plasma corin concentration from preoperative baseline. Further investigation is warranted to determine the role of corin in postoperative HF biology.
Corin是一种利钠肽转化酶,可将前体B型利钠肽原裂解为活性B型利钠肽(BNP)(具有利尿、利钠和血管舒张特性)。血浆BNP升高是门诊和手术患者已知的心力衰竭(HF)诊断和预后生物标志物。最近的研究表明,慢性HF患者的血浆Corin显著降低,但心脏手术患者的围手术期血浆Corin浓度尚未得到评估。本研究的目的是确定冠状动脉旁路移植术(CABG)联合体外循环(CPB)手术对血浆Corin浓度的影响,并评估围手术期血浆Corin浓度变化与术后长期HF住院或死亡之间的关联。研究假设术后第1至4天血浆Corin浓度较术前基线水平显著降低,且术后5年内因HF住院或死亡与血浆Corin浓度的相对差异(术前基线至术后最低点)较高有关。
前瞻性观察性试点研究。
两个机构:马萨诸塞州波士顿的布里格姆妇女医院和得克萨斯州休斯顿的圣卢克医院德克萨斯心脏研究所。
99名接受CPB下单纯原发性CABG手术的欧洲血统患者。
CPB下非急诊单纯原发性CABG手术。
术前和术后4个时间点(术后第1 - 4天)评估血浆Corin浓度。通过查阅医院和死亡记录确定术后5年内的HF住院或HF死亡事件。术后血浆Corin浓度显著低于术前基线浓度(p<0.0001)。围手术期Corin浓度男性显著高于女性(p<0.0001)。15名患者发生术后长期HF事件。在研究随访期间发生HF住院或HF死亡的患者,其血浆Corin浓度的相对差异(术前基线至术后最低点)显著高于在研究随访期间未发生HF事件的患者(p = 0.03)。
CABG手术后血浆Corin浓度较术前浓度显著降低。CPB下CABG手术后5年内HF住院或HF死亡与血浆Corin浓度从术前基线水平的相对降幅较大有关。有必要进一步研究以确定Corin在术后HF生物学中的作用。